Items Tagged ‘Matthew Ferber’
August 20, 2020
Could population genetic screening improve public health?
Hereditary BRCA-related breast and ovarian cancer, Lynch syndrome and familial hypercholesterolemia are estimated to be relatively prevalent in the general population but poorly found using traditional risk screening. In a typical medical practice, genetic testing for these conditions is based on personal or family history, ethnic background or other demographic characteristics, that may not always […]
Tags: breast cancer, cancer genomics, Center for Individualized Medicine, genetic testing, genetics, hereditary cancer, hereditary diseases, Lynch syndrome, Matthew Ferber, ovarian cancer, population health
April 19, 2018
Direct-to-consumer genetic testing-a rapidly shifting landscape
Direct-to-consumer genetic or over the counter testing emerged in the early 2000s as a means of allowing consumers to access information about their genetics without the involvement of a physician. While early models were popular with consumers, they were controversial in medical and regulatory circles. In the January 2018 issue of Mayo Clinic Proceedings authors Megan Allyse Ph.D., […]
Tags: biomedical ethics, Center for Individualized Medicine, Matthew Ferber, Mayo Clinic Proceedings, Megan Allyse, precision medicine, Richard Sharp
March 28, 2017
Next generation sequencing – a game changer
Article by Sharon Rosen Imagine scanning a page for errors manually one letter at a time, versus using a faster tool like spell check. That’s the difference between the first DNA sequencing methods and the new computerized machines known as next generation sequencing. It’s revolutionizing health care. Next generation sequencing technology enables geneticists to examine […]
Tags: Center for Individualized Medicine, genetic testing, genetics, Matthew Ferber, pathology, Pavel Pichurin